Tidewater Clinical Research
Chesapeake, Virginia 23320
2 studies enrolling now · 3 studies all time
What they study most
Primary Sjogren's Disease, Rheumatoid Arthritis, Sjogrens Syndrome
Studies at this site
- A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors) — Recruiting now
- Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease — Recruiting now
- Nipocalimab in Moderate to Severe Sjogren's Disease — Running, not enrolling